Enovix Co. (NASDAQ:ENVX – Get Free Report) was the target of a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 52,780,000 shares, a growth of 6.6% from the August 31st total of 49,510,000 shares. Approximately 35.8% of the shares of the stock are short sold. Based on an average trading volume of 6,240,000 shares, the short-interest ratio is currently 8.5 days.
Enovix Price Performance
Shares of ENVX stock opened at $8.58 on Wednesday. The company has a debt-to-equity ratio of 0.97, a quick ratio of 3.84 and a current ratio of 3.98. Enovix has a fifty-two week low of $5.70 and a fifty-two week high of $18.68. The firm has a market cap of $1.51 billion, a P/E ratio of -6.40 and a beta of 1.99. The business’s 50 day moving average price is $10.26 and its 200-day moving average price is $10.55.
Enovix (NASDAQ:ENVX – Get Free Report) last released its quarterly earnings results on Wednesday, July 31st. The company reported ($0.25) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.04. Enovix had a negative net margin of 1,434.34% and a negative return on equity of 91.21%. The business had revenue of $3.77 million for the quarter, compared to analysts’ expectations of $3.85 million. On average, equities research analysts anticipate that Enovix will post -1.21 earnings per share for the current year.
Institutional Trading of Enovix
Analysts Set New Price Targets
A number of brokerages have recently weighed in on ENVX. Benchmark began coverage on shares of Enovix in a report on Monday, July 22nd. They issued a “buy” rating and a $25.00 price objective for the company. Oppenheimer restated an “outperform” rating and set a $36.00 price target on shares of Enovix in a research report on Monday, August 26th. B. Riley upgraded Enovix to a “strong-buy” rating in a report on Tuesday, June 25th. Craig Hallum boosted their target price on Enovix from $15.00 to $20.00 and gave the company a “buy” rating in a research note on Thursday, August 1st. Finally, Piper Sandler restated an “overweight” rating and set a $19.00 price target (down from $23.00) on shares of Enovix in a research report on Monday, August 5th. One analyst has rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Enovix presently has a consensus rating of “Buy” and an average price target of $21.33.
View Our Latest Analysis on ENVX
Enovix Company Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Read More
- Five stocks we like better than Enovix
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Conference Calls and Individual Investors
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What Investors Need to Know to Beat the Market
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.